2020
April
Public Domain by NIAID Rocky Mountain Laboratories (RML), U.S. NIH
| A trial drug, APN01, seems to block early stages of the COVID-19 virus from spreading in cell cultures. It holds promise for the development of medication to treat early infections with the COVID-19 coronavirus. |